Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/01/25 → 8/01/30 |
Clinical Trial Phase
- Phase III (a & b)
A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Chemotherapy
- Herbison, Harriet (Primary Chief Investigator (PCI))
Project: Research